RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of BEAT
Powered by GPT-4o
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Big movements in BioTelemetry stock price on Tuesday moving 32.11% between high and low
(Updated on Jul 02, 2024)

Buy or Hold candidate since Jun 27, 2024 Gain 17.53% PDF

The BioTelemetry stock price gained 18.95% on the last trading day (Tuesday, 2nd Jul 2024), rising from $2.48 to $2.95. During the last trading day the stock fluctuated 32.11% from a day low at $2.45 to a day high of $3.23. The price has risen in 8 of the last 10 days and is up by 24.47% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 500 thousand more shares were traded than the day before. In total, 550 thousand shares were bought and sold for approximately $1.62 million.

The stock lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 25.70% during the next 3 months and, with a 90% probability hold a price between $2.72 and $4.01 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

BEAT Signals & Forecast

The BioTelemetry stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $2.55 and $2.46. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Thursday, June 13, 2024, and so far it has risen 44.61%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume is rising along with the price. This is considered to be a good technical signal.

Support, Risk & Stop-loss for BioTelemetry stock

BioTelemetry finds support from accumulated volume at $2.92 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.785 between high and low, or 32.11%. For the last week, the stock has had daily average volatility of 12.67%.

Our recommended stop-loss: $2.84 (-3.56%) (This stock has high daily movements and this gives high risk. There is a buy signal from a pivot bottom found 24 days ago.)

Trading Expectations (BEAT) For The Upcoming Trading Day Of Wednesday 3rd

For the upcoming trading day on Wednesday, 3rd we expect BioTelemetry to open at $2.88, and during the day (based on 14 day Average True Range), to move between $2.70 and $3.20, which gives a possible trading interval of +/-$0.252 (+/-8.54%) up or down from last closing price. If BioTelemetry takes out the full calculated possible swing range there will be an estimated 17.08% move between the lowest and the highest trading price during the day.

With no resistance above and support from accumulated volume @ $2.92, some $0.0300 (1.02%) from the current price of $2.95, our system finds the risk reward attractive.

Is BioTelemetry stock A Buy?

BioTelemetry holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Hold/Accumulate candidate.

Current score: 0.000 Hold/Accumulate Downgraded

Zero in score indicates that our system is expecting high volatility and risk for the following trading day. Given the latest developments, we cannot determine the next direction as it may go both ways.

Predicted Opening Price for BioTelemetry of Wednesday, July 3, 2024

Fair opening price July 3, 2024 Current price
$2.88 ( 2.54%) $2.95

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for BEAT

Fibonacci Support & Resistance Levels

Level Price
R3 3.66 24.07%
R2 3.36 13.90%
R1 3.17 7.62%
Price 2.95
S1 2.58 -12.71%
S2 2.39 -18.99%
S3 2.09 -29.15%

Accumulated Volume Support & Resistance Levels

Level Price
R3 0 -
R2 0 -
R1 0 -
Price 2.95
S1 2.92 -1.02%
S2 2.72 -7.80%
S3 2.53 -14.24%

FAQ

What is the symbol for BioTelemetry Stock and on which exchange is it traded?
The symbol for BioTelemetry is BEAT and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell BioTelemetry Stock?
BioTelemetry holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Hold/Accumulate candidate.

How to buy BioTelemetry Stock?
BioTelemetry Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy BioTelemetry Stock.

What's the current price of BioTelemetry Stock?
As of the end of day on the Jul 02, 2024, the price of an BioTelemetry (BEAT) share was $2.95.

What is the 52-week high and low for BioTelemetry Stock?
The 52-week high for BioTelemetry Stock is $3.74 and the 52-week low is $1.06.

What is the market capitalization of BioTelemetry Stock?
As of the Jul 02, 2024, the market capitalization of BioTelemetry is 65.296M.

When is the next earnings date for BioTelemetry?
The upcoming earnings date for BioTelemetry is Aug 08, 2024.
Click to get the best stock tips daily for free!

About BioTelemetry

BioTelemetry HeartBeam, Inc., a medical technology company, primarily focuses on telemedicine solutions for the detection and monitoring of cardiac disease outside a healthcare facility setting. The company also focuses on providing diagnostic data to physicians with care management of patients with cardiovascular disease. Its telehealth product comprises a credit card sized electrocardiogram machine and a cloud-based diagnostic software system to address the... BEAT Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT